Saliha Rizvi M.Sc (University of Lucknow); Ph.D (Amity University)
Assistant Professor, Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh · India
Editorial leadership for Journal of Clinical Case Reports and Images ISSN 2641-5518
Research interests
- Molecular Genetics
- Metabolic Syndrome
- Cancer
- Micro-Rna
- Gene Polymorphism
- Personalized Medicine
Biography
Dr. Saliha Rizvi, MSc, PhD, is an Assistant Professor at Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India. She completed her advanced studies at the University of Lucknow and Amity University. Her research focuses on molecular genetics, metabolic syndrome, cancer, micro-RNA, and gene polymorphism. Dr. Rizvi's most-cited publication, "Implication of single nucleotide polymorphisms in Interleukin-10 gene (rs1800896 and rs1800872) with severity of COVID-19" (2022), reflects her contributions to understanding genetic factors in disease susceptibility and progression.
Selected publications
- Implication of single nucleotide polymorphisms in Interleukin-10 gene (rs1800896 and rs1800872) with severity of COVID-19 2022 cited 18×
- Genetic modifiers of epilepsy: A narrative review Recent 2025 cited 3×
- Probiotics in Diabetes Mellitus 2024 cited 2×
- Association of AGT and AGTR1 gene polymorphisms with chronic kidney disease: a case-control and in silico study Recent 2025 cited 1×
- Association of Single Nucleotide Polymorphism in OCT1 and OCT3 Genes with the Efficacy of Metformin Response in North Indian Type 2 Diabetes Mellitus Patients 2024 cited 1×
- Pharmacokinetics and lipid-lowering efficacy affected by polymorphisms in genetic variability in statin therapy Recent 2025 cited 1×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCCI for your work?
This journal is guided by Saliha Rizvi (Assistant Professor, Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.